Here's What Roth Capital Thinks of Equillium (EQ) Stock [Yahoo! Finance]
Equillium, Inc. (EQ)
Last equillium, inc. earnings: 3/26 04:07 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
13, Roth Capital analyst Adam Walsh initiated coverage of Equillium, Inc. (NASDAQ:EQ), assigning a Buy rating and a price target of $12. The firm's assigned price target suggests a compelling 458% upside from the current levels. The firm noted that Equillium's EQ504, an oral colon-targeted therapy, is entering Phase 1 trials for ulcerative colitis, using a mechanism that has already been validated. Despite this advancement, the analyst highlighted that the stock is currently trading as if it held an unproven asset, indicating a potential upside for investors who recognize the value of the drug's clinical and scientific progress. 10 Best Biotech Stocks To Buy Under $20 On the same day, Equillium, Inc. (NASDAQ:EQ) announced another development. The company entered into a definitive securities purchase agreement with RA Capital Management to raise approximately $35 million in gross proceeds. As part of the agreement, the company will issue around 18.9 million shares of its common sto
Show less
Read more
Impact Snapshot
Event Time:
EQ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EQ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EQ alerts
High impacting Equillium, Inc. news events
Weekly update
A roundup of the hottest topics
EQ
News
- Equillium GAAP EPS of -$0.04 beats by $0.02, revenue of $0M [Seeking Alpha]Seeking Alpha
- Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights [Yahoo! Finance]Yahoo! Finance
- Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical HighlightsGlobeNewswire
- Equillium to Participate in the 38th Annual Roth ConferenceGlobeNewswire
- Equillium Announces $35 Million Financing with RA Capital Management [Yahoo! Finance]Yahoo! Finance
EQ
Earnings
- 3/27/25 - Beat
EQ
Sec Filings
- 3/26/26 - Form EFFECT
- 3/25/26 - Form S-8
- 3/25/26 - Form 10-K
- EQ's page on the SEC website